151 related articles for article (PubMed ID: 27777428)
1. Sarcopenia and American Society of Anesthesiologists Physical Status in the Assessment of Outcomes of Hepatocellular Carcinoma Patients Undergoing Hepatectomy.
Takagi K; Yagi T; Yoshida R; Shinoura S; Umeda Y; Nobuoka D; Kuise T; Watanabe N; Fujiwara T
Acta Med Okayama; 2016 Oct; 70(5):363-370. PubMed ID: 27777428
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma.
Voron T; Tselikas L; Pietrasz D; Pigneur F; Laurent A; Compagnon P; Salloum C; Luciani A; Azoulay D
Ann Surg; 2015 Jun; 261(6):1173-83. PubMed ID: 24950264
[TBL] [Abstract][Full Text] [Related]
3. Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma.
Hamaguchi Y; Kaido T; Okumura S; Ito T; Fujimoto Y; Ogawa K; Mori A; Hammad A; Hatano E; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Jun; 22(6):475-85. PubMed ID: 25755128
[TBL] [Abstract][Full Text] [Related]
4. Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Taura K; Hatano E; Okajima H; Uemoto S
J Hepatobiliary Pancreat Sci; 2016 Jan; 23(1):57-64. PubMed ID: 26572789
[TBL] [Abstract][Full Text] [Related]
5. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.
Harimoto N; Shirabe K; Yamashita YI; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y; Nishie A; Yamanaka T
Br J Surg; 2013 Oct; 100(11):1523-30. PubMed ID: 24037576
[TBL] [Abstract][Full Text] [Related]
7. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
[TBL] [Abstract][Full Text] [Related]
8. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection.
Polvieng T; Hongjinda S; Thienhiran A; Burasakarn P; Fuengfoo P
Am Surg; 2024 Jun; 90(6):1447-1455. PubMed ID: 38516765
[TBL] [Abstract][Full Text] [Related]
9. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma.
Takagi K; Yagi T; Umeda Y; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Araki H; Fujiwara T
World J Surg; 2017 Sep; 41(9):2353-2360. PubMed ID: 28389736
[TBL] [Abstract][Full Text] [Related]
11. Impact of Sarcopenia as a Prognostic Factor on Reductive Hepatectomy for Advanced Hepatocellular Carcinoma.
Omiya S; Komatsu S; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Sofue K; Yano Y; Sakai Y; Yanagimoto H; Toyama H; Ajiki T; Fukumoto T
Anticancer Res; 2021 Nov; 41(11):5775-5783. PubMed ID: 34732451
[TBL] [Abstract][Full Text] [Related]
12. Combination of sarcopenia and prognostic nutritional index to predict long-term outcomes in patients undergoing initial hepatectomy for hepatocellular carcinoma.
Hayashi H; Shimizu A; Kubota K; Notake T; Masuo H; Yoshizawa T; Hosoda K; Sakai H; Yasukawa K; Soejima Y
Asian J Surg; 2023 Feb; 46(2):816-823. PubMed ID: 35961897
[TBL] [Abstract][Full Text] [Related]
13. Muscle Steatosis is an Independent Predictor of Postoperative Complications in Patients with Hepatocellular Carcinoma.
Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Fujimoto Y; Ogawa K; Mori A; Hammad A; Hatano E; Uemoto S
World J Surg; 2016 Aug; 40(8):1959-68. PubMed ID: 27071610
[TBL] [Abstract][Full Text] [Related]
14. Predictors of poor prognosis by recurrence patterns after curative hepatectomy for hepatocellular carcinoma in Child-Pugh classification A.
Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
Hepatogastroenterology; 2015; 62(137):164-8. PubMed ID: 25911889
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
Meza-Junco J; Montano-Loza AJ; Baracos VE; Prado CM; Bain VG; Beaumont C; Esfandiari N; Lieffers JR; Sawyer MB
J Clin Gastroenterol; 2013; 47(10):861-70. PubMed ID: 23751844
[TBL] [Abstract][Full Text] [Related]
16. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
17. Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma.
Yang J; Chen K; Zheng C; Chen K; Lin J; Meng Q; Chen Z; Deng L; Yu H; Deng T; Bo Z; He Q; Wang Y; Chen G
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2383-2392. PubMed ID: 35854105
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.
Hirokawa F; Hayashi M; Asakuma M; Shimizu T; Inoue Y; Uchiyama K
Surg Oncol; 2016 Mar; 25(1):24-9. PubMed ID: 26979637
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
20. Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma.
Seror M; Sartoris R; Hobeika C; Bouattour M; Paradis V; Rautou PE; Soubrane O; Vilgrain V; Cauchy F; Ronot M
Ann Surg Oncol; 2021 Jan; 28(1):405-416. PubMed ID: 32965614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
